Welcome, ladies and gentlemen, to AstraZeneca's full-year and Q4 2024 results conference call for investors and analysts. Before I hand over to AstraZeneca, I'd like to read the safe harbor statement.
Rachel Reeves has suffered a humiliating blow to her hopes win back business confidence after AstraZeneca has cancelled a planned £450 million investment in a vaccine manufacturing plant in ...
Meet Minnesota Orchestra’s Susie Park. Pharmaceutical company AstraZeneca on Friday cancelled a planned 450 million-pound ($560 million) investment in a vaccine manufacturing plant in northwest ...
AstraZeneca has cancelled plans for a £450m vaccine manufacturing plant in Liverpool, blaming a cut in funding from government. The investment, announced last year in the Tories' spring budget ...
AstraZeneca Calls Off Vaccine Hub Investment Over UK Funding Drugmaker planned to invest £450 million in Liverpool site Decision is setback for Labour government’s growth push ...
Confirming the reversal on Friday, a spokesperson for AstraZeneca said: "Following discussions with ... “I want to unlock that full potential, which is why we've announced a number of investments ...
AstraZeneca has pulled out of plans to build a new £450m facility in Liverpool. AstraZeneca, which produced one of the Covid-19 jabs, has an existing site on Renaissance Way, Speke and during the ...
But a spokesman for AstraZeneca said today: 'Following discussions with the current Government, we are no longer pursuing our planned investment in Speke. 'Several factors have influenced this ...
LONDON — Pharmaceutical company AstraZeneca on Friday cancelled a planned 450 million-pound ($560 million) investment in a vaccine manufacturing plant in northwest England, blaming the new ...
This is hardly the first time AstraZeneca has bristled at the U.K.’s business environment for the life sciences industry. Back in February 2023, AZ CEO Pascal Soriot attributed the company’s ...
AstraZeneca has dropped its plans to invest £450m in a vaccine manufacturing plant in Speke, Merseyside, blaming a reduction in government support. The move will be seen as a major blow to ...
LONDON, Jan 31 (Reuters) - AstraZeneca (AZN.L), opens new tab on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in northern England ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results